| Literature DB >> 35900675 |
N Shamsi Gamchi1, M Esmaeili2.
Abstract
Infectious diseases drive countries to provide vaccines to individuals. Due to the limited supply of vaccines, individuals prioritize receiving vaccinations worldwide. Although, priority groups are formed based on age groupings due to the restricted decision-making time. Governments usually ordain different health protocols such as lockdown policy, mandatory use of face masks, and vaccination during the pandemics. Therefore, this study considers the case of COVID-19 with a SEQIR (susceptible-exposed-quarantined-infected-recovered) epidemic model and presents a novel prioritization technique to minimize the social and economic impacts of the lockdown policy. We use retail units as one of the affected parts to demonstrate how a vaccination plan may be more effective if individuals such as retailers were prioritized and age groups. In addition, we estimate the total required vaccine doses to control the epidemic disease and compute the number of vaccine doses supplied by various suppliers. The vaccine doses are determined using optimal control theory in the solution technique. In addition, we consider the effect of the mask using policy in the number of vaccine doses allocated to each priority group. The model's performance is evaluated using an illustrative scenario based on a real case.Entities:
Keywords: Infectious disease; Mandatory use of face mask; Optimal control; Parallel prioritization; SEQIR epidemic model; Vaccine allocation
Year: 2022 PMID: 35900675 PMCID: PMC9330986 DOI: 10.1007/s10198-022-01491-5
Source DB: PubMed Journal: Eur J Health Econ ISSN: 1618-7598
Fig. 1SEQIR epidemic model of COVID-19 without control [18]. Given the transmission rates in the epidemic model, individuals’ states change when there are contacts among susceptible individuals and quarantined or exposed ones. Moreover, based on the severity of the disease, their states switch to infected or recovered. In addition, the natural death rate or death rate of infected individuals affects the number of individuals in each state. Different compartments, including susceptible, exposed, quarantined, infected, and recovered, are shown in the figure. The transmission rates between the compartments, the natural death rate, and the death rate due to the COVID-19 are presented. Notably, this figure shows the dynamic of the disease before using the control tools
Fig. 2SEQIR epidemic model of COVID-19 considering control variables. Compared to Fig. 1, when there is a control tool such as vaccination, some susceptible individuals get immune to the disease. They move to the recovered individuals decreasing the number of exposed, quarantined, or infected ones. In addition, using a face mask protects the susceptible individuals against the disease, reducing their number. This figure is the same as the previous one, and the difference is that the effect of using the control tools is considered
Fig. 3Age group-based population of Tehran. The most populated age group in Tehran is the range of 25 to 39, which affects the immunization program’s efficiency if it is based on the age groups. A graph with vertical bars depicts the distribution of age groups in Tehran. The Y-axis is labeled as “No. of individuals,” and the X-axis is labeled as “Age groups,” ranging from 0–4 to 100+
Input parameters of presented epidemic model
| Rate | Value (G1, G2, G3) | Estimated based on |
|---|---|---|
| 0.42, 0.45, 0.47 | Iran health minister’s report | |
| 0.60, 0.60, 0.60 | [ | |
| 0.55, 0.53, 0.52 | [ | |
| 0.8, 0.78, 0.75 | Iran health minister’s report | |
| 0.53, 0.53, 0.53 | [ | |
| 0.65, 0.64, 0.61 | Iran health minister’s report | |
| 0.0625, 0.0610, 0.0598 | [ | |
| 0.09, 0.09, 0.09 | [ | |
| 0.70, 0.73, 0.77 | [ | |
| 0.41, 0.40, 0.40 | Iran health minister’s report |
Fig. 4Dynamics of the COVID-19 epidemic disease before using control tools. In the first weeks of infectious disease spread out, the number of susceptible individuals decreases because there are no health protocols like face masks. Consequently, the infection rate is high. During this time, the number of susceptible ones increase, and because of the death that occurred by the disease, the number of infected, recovered and exposed decrease. The status of each compartment over the 40 weeks before using the control tools is shown in the figure. There are five different graphs that each one is related to a compartment in the dynamic system
Fig. 5Dynamics of the COVID-19 epidemic disease after vaccination and mandatory use of face mask as control tools. Using the face mask and vaccination of individuals, the number of susceptible individuals and, consequently, the number of exposed and infected ones decreases. In addition, the number of recovered individuals increases. The status of each compartment over the 50 weeks after using the control tools is shown in the figure. There are five different graphs that each one is related to a compartment in the dynamic system
Fig. 6Control function of using face mask (priority group G1). This curve shows that mandatory use of the face mask long-term impacts on epidemic control. The graph shows the value of the second control tool, i.e., mandatory use of face mask, over time. The Y-axis is labeled as “using face mask as a control tool” and the X-axis is labeled as “Time (weeks),” which indicates the time of controlling the epidemic using this control variable
Fig. 7Control function of vaccinating (priority group G1). This figure shows the effect of vaccination, which controls the epidemic disease 25 weeks after starting the immunization program. Notably, mandatory use of face masks also influences the time of epidemic control. The graph shows the value of the first control tool, i.e., vaccination, over time. The Y-axis is labeled as “vaccination as a control tool,” and the X-axis is labeled as “Time (weeks),” which indicates the time of controlling the epidemic using this control variable
Results of epidemic control by vaccination as a control tool
| Priority group | Required number of vaccine doses | Time of control |
|---|---|---|
| 90% efficacy | ||
| G1 | 3,295,598 doses | About 25 weeks |
| G2 | 1,833,120 doses | About 19 weeks |
| G3 | 1,606,747 doses | About 15 weeks |
| Total | 6,735,465 doses | About 25 weeks |
Fig. 8Total social cost and economic cost without considering the parallel prioritization. The area under the curves shows the total social and economic costs in different situations. The total cost in the case of parallel vaccination is lower than the other situation. Two different graphs in the figure compare the number of susceptible individuals in two cases of using face masks and not using them, which affect the number of vaccines allocated to each group
| Index of suppliers ( | |
| Index of priority groups ( | |
| Index of businesses that affected by lockdown policy ( |
| Price of each vaccine dose from supplier | |
| Capacity of supplier | |
| Cost of locking down business | |
| Social cost caused by infected individuals of the group | |
| Number of susceptible individuals of the group | |
| Number of exposed individuals of the group | |
| Number of quarantined individuals of the group | |
| Number of infected individuals of the group | |
| Number of recovered individuals of the group | |
| The recruitment rate of priority group | |
| The transmission rate from susceptible population to infected of priority group | |
| The transmission rate from susceptible population to quarantine population of priority group | |
| The transmission rate from infected but not detected by testing population to quarantine population of priority group | |
| The transmission rate from infected but not detected by testing population to secured zone population of the priority group | |
| The transmission rate from quarantine population to secured zone population of priority group | |
| The transmission rate from infected but not detected by testing population to infected population of priority group | |
| The transmission rate from quarantine population to infected population of priority group | |
| The natural death rate of all sub-populations in priority group | |
| The death rate of infected population due to COVID-19 in priority group | |
| Basic reproduction number of the priority group | |
| The time at which the epidemic in the priority group | |
| Fixed cost of the vaccination program | |
| Fixed cost of implementing the policy of using a face mask | |
| Start time of the priority group |
| Number of vaccine doses supplied by the supplier | |
| The proportion of susceptible individuals of the priority group | |
| The proportion of susceptible individuals of the priority group | |
| Number of vaccine doses required to immunize the priority group |